Automated Ambulatory Blood Pressure Monitoring

Excerpt

Estimates of the prevalence of hypertension in the United States have been varied. Recently, the National Heart, Lung, and Blood Institute (1) estimated that there are 58 million hypertensive persons in the United States. Of these 58 million, approximately half have only mild elevations in blood pressure (1). Large-scale prospective, epidemiologic, actuarial studies have shown that high blood pressure is a major independent risk factor for common adult cardiovascular-renal diseases including coronary heart disease, cerebral vascular disease, aortic aneurysm, and peripheral vascular disease (2-5). Sixty percent of all heart attacks and two thirds of all strokes occur in persons who

This 100-word excerpt has been provided in the absence of an abstract.

Acknowledgments

ACKNOWLEDGMENTS: The Clinical Efficacy Assessment Project (CEAP) of the American College of Physicians is designed to evaluate and inform College members and others about the safety and efficacy of diagnostic and therapeutic modalities. Evaluation of technologies begins with a notice in Annals of Internal Medicine and the ACP Observer inviting comments. Appropriate members of the Council of Medical Societies and the Council of Subspecialty Societies as well as other experts are asked to review technologies. The CEAP statements thus represent a synthesis of the literature and expert opinion and are intended to reflect the current state-of-the-art knowledge concerning a technology. Statements may be reconsidered as new information becomes available.

Article and Author Information

  • * This paper was authored by Constance Monroe Winslow, M.D., and was developed for the Health and Public Policy Committee by the Clinical Efficacy Assessment Subcommittee: Richard G. Farmer, M.D., Chairman; Lockhart McGuire, M.D.; Earl Steinberg, M.D.; Richard B. Hornick, M.D.; John S. Davis, IV, M.D.; Harold C. Sox, M.D. Members of the Health and Public Policy Committee for the 1985-86 term include Edwin P. Maynard III, M.D., Chairman; John H. Eisenberg, M.D.; Richard G. Farmer, M.D.; Boy Frame, M.D.; John R. Hogness, M.D.; William L. Hughes, M.D.; Charles E. Lewis, M.D.; Malcolm L. Peterson, M.D.; Richard J. Reitemeier, M.D.; Helen L. Smits, M.D.; and Paul D. Stolley, M.D. This paper was adopted by the Board of Regents on 26 July 1985.

  • ▸Requests for reprints should be addressed to Linda Johnson White; Clinical Efficacy Assessment Project, Department of Health and Public Policy, American College of Physicians, 4200 Pine Street; Philadelphia, PA 19104.

| Table of Contents
Most Read Most Read
Most Commented Most Commented On
Annals in the News Annals in the News
Clinical Trials Clinical Trials
Comparative Effectiveness Comparative Effectiveness
Hospital Medicine Hospital Medicine
  • Advertisement
  • Advertisement